HOME
 
WELCOME TO SORRENTO THERAPEUTICS
 

Sorrento Therapeutics, Inc. is a development-stage biopharmaceutical company focused on applying its proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic disease and infectious disease. The Company has constructed antibody libraries containing fully human antibodies and designed to facilitate the rapid identification and isolation of highly specific, antibody therapeutic product candidates that are fully human and that bind to disease targets appro...

 
PRESS RELEASE
Hacked by mr.0x3a....
mr.0x3a was here... Ashiyane Digital Security team
July 28 , 2011
Frost & Sullivan Lauds Sorrento Therapeutics for Making Strides in the Global Biopharmaceutical Market
LONDON, June 9 /PRNewswire/ -- Based on its recent research, Frost & Sullivan presents Sorrento Therapeuti...
June 09 , 2010
  
 
TECHNOLOGY

 

Sorrento Therapeutics applies a proprietary platform, the STI technology, for the construction of fully human antibody libraries.The STI Technology uses RNA transcription for the amplification of variable immunoglobulin domain sequences.
TECHNOLOGY ACCESS



STI is interested to enter into technology access partnerships with pharmaceutical and biopharmaceutical partners.
As of today we offer technology licenses for well defined uses, access to our proprietary library to screen your target and library construction services for fully human antibody libraries from partner specified patient populations.
CONTACT US

Sorrento Therapeutics, Inc.
6042 Cornerstone Ct. West, Suite B
San Diego, CA 92121
+1 (858) 210-3700

AWARD